Cargando…

PSPC1 potentiates TGF-β-dependent metastatic dissemination

Metastatic reprogramming toward malignant tumor progression relies on the activation of oncogenic regulators, yet the cellular determinants remain elucidated. Through identification of aberrant prognostic cancer genes, we identified paraspeckle component 1 (PSPC1) functions as a master activator of...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeh, Hsi-Wen, Jou, Yuh-Shan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6149759/
https://www.ncbi.nlm.nih.gov/pubmed/30250921
http://dx.doi.org/10.1080/23723556.2018.1472058
_version_ 1783356862529273856
author Yeh, Hsi-Wen
Jou, Yuh-Shan
author_facet Yeh, Hsi-Wen
Jou, Yuh-Shan
author_sort Yeh, Hsi-Wen
collection PubMed
description Metastatic reprogramming toward malignant tumor progression relies on the activation of oncogenic regulators, yet the cellular determinants remain elucidated. Through identification of aberrant prognostic cancer genes, we identified paraspeckle component 1 (PSPC1) functions as a master activator of metastatic reprogramming by activating epithelial-to-mesenchymal transition (EMT), stemness and TGF-β1 pro-metastatic switch.
format Online
Article
Text
id pubmed-6149759
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-61497592019-08-01 PSPC1 potentiates TGF-β-dependent metastatic dissemination Yeh, Hsi-Wen Jou, Yuh-Shan Mol Cell Oncol Author's Views Metastatic reprogramming toward malignant tumor progression relies on the activation of oncogenic regulators, yet the cellular determinants remain elucidated. Through identification of aberrant prognostic cancer genes, we identified paraspeckle component 1 (PSPC1) functions as a master activator of metastatic reprogramming by activating epithelial-to-mesenchymal transition (EMT), stemness and TGF-β1 pro-metastatic switch. Taylor & Francis 2018-08-01 /pmc/articles/PMC6149759/ /pubmed/30250921 http://dx.doi.org/10.1080/23723556.2018.1472058 Text en © 2018 The Author(s). Published by Taylor & Francis. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
spellingShingle Author's Views
Yeh, Hsi-Wen
Jou, Yuh-Shan
PSPC1 potentiates TGF-β-dependent metastatic dissemination
title PSPC1 potentiates TGF-β-dependent metastatic dissemination
title_full PSPC1 potentiates TGF-β-dependent metastatic dissemination
title_fullStr PSPC1 potentiates TGF-β-dependent metastatic dissemination
title_full_unstemmed PSPC1 potentiates TGF-β-dependent metastatic dissemination
title_short PSPC1 potentiates TGF-β-dependent metastatic dissemination
title_sort pspc1 potentiates tgf-β-dependent metastatic dissemination
topic Author's Views
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6149759/
https://www.ncbi.nlm.nih.gov/pubmed/30250921
http://dx.doi.org/10.1080/23723556.2018.1472058
work_keys_str_mv AT yehhsiwen pspc1potentiatestgfbdependentmetastaticdissemination
AT jouyuhshan pspc1potentiatestgfbdependentmetastaticdissemination